相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis
Kai Jiang et al.
PROTEIN & CELL (2022)
Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis
Narjes Nasiri-Ansari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Activation of autophagy and suppression of apoptosis by dapagliflozin attenuates experimental inflammatory bowel disease in rats: Targeting AMPK/mTOR, HMGB1/RAGE and Nrf2/HO-1 pathways
Hany H. Arab et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2021)
Dapagliflozin ameliorates pancreatic injury and activates kidney autophagy by modulating the AMPK/mTOR signaling pathway in obese rats
Krit Jaikumkao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
Ralph A. DeFronzo et al.
NATURE REVIEWS NEPHROLOGY (2021)
The SGLT2 inhibitor empagliflozin negatively regulates IL-17/IL-23 axis-mediated inflammatory responses in T2DM with NAFLD via the AMPK/mTOR/autophagy pathway
Ziyu Meng et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Sodium-Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK-mTOR Signaling Pathway-Mediated Autophagy
Changzhen Ren et al.
FRONTIERS IN PHARMACOLOGY (2021)
Dapagliflozin Alleviates Hepatic Steatosis by Restoring Autophagy via the AMPK-mTOR Pathway
Liuran Li et al.
FRONTIERS IN PHARMACOLOGY (2021)
HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
Kiichi Hirota
BIOMEDICINES (2021)
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
Erik J. M. van Bommel et al.
KIDNEY INTERNATIONAL (2020)
Podocytes maintain high basal levels of autophagy independent of mtor signaling
Tillmann Bork et al.
AUTOPHAGY (2020)
Endothelial autophagy deficiency induces IL6-dependent endothelial mesenchymal transition and organ fibrosis
Yuta Takagaki et al.
AUTOPHAGY (2020)
Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease: Evidence and Therapeutic Potential
Kristen L. Nowak et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Autophagy stimulation and intracellular sodium reduction as mediators of the cardioprotective effect of sodium-glucose cotransporter 2 inhibitors
Milton Packer
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Autophagy Deficiency in Renal Proximal Tubular Cells Leads to an Increase in Cellular Injury and Apoptosis under Normal Fed Conditions
Chigure Suzuki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Metformin alleviates oxidative stress and enhances autophagy in diabetic kidney disease via AMPK/SIRT1-FoxO1 pathway
Huiwen Ren et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2020)
Canagliflozin inhibits p-gp function and early autophagy and improves the sensitivity to the antitumor effect of doxorubicin
Jin Zhong et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Role of Deranged Energy Deprivation Signaling in the Pathogenesis of Cardiac and Renal Disease in States of Perceived Nutrient Overabundance
Milton Packer
CIRCULATION (2020)
Lysosomal Exocytosis, Exosome Release and Secretory Autophagy: The Autophagic- and Endo-Lysosomal Systems Go Extracellular
Sandra Buratta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in db/db Mice, a Model of Type 2 Diabetes
Anton I. Korbut et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose Cotransporter 2-Inhibitors
Milton Packer
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition
Issei Tomita et al.
CELL METABOLISM (2020)
Molecular, Cellular, and Clinical Evidence That Sodium-Glucose Cotransporter 2 Inhibitors Act as Neurohormonal Antagonists When Used for the Treatment of Chronic Heart Failure
Milton Packer
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
SIRT1 Activation by Natural Phytochemicals: An Overview
Concetta Iside et al.
FRONTIERS IN PHARMACOLOGY (2020)
Sodium Glucose Co-Transporter 2 Inhibitor Ameliorates Autophagic Flux Impairment on Renal Proximal Tubular Cells in Obesity Mice
Kazuhiko Fukushima et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control
Martin R. Cowie et al.
NATURE REVIEWS CARDIOLOGY (2020)
Cardioprotective Effects of Sirtuin-1 and Its Downstream Effectors Potential Role in Mediating the Heart Failure Benefits of SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors
Milton Packer
CIRCULATION-HEART FAILURE (2020)
Dapagliflozin improves behavioral dysfunction of Huntington's disease in rats via inhibiting apoptosis-related glycolysis
Ayman E. El-Sahar et al.
LIFE SCIENCES (2020)
Age-dependent loss of adipose Rubicon promotes metabolic disorders via excess autophagy
Tadashi Yamamuro et al.
NATURE COMMUNICATIONS (2020)
TLR9 Binding to Beclin 1 and Mitochondrial SIRT3 by a Sodium-Glucose Co-Transporter 2 Inhibitor Protects the Heart from Doxorubicin Toxicity
Chao-Yung Wang et al.
BIOLOGY-BASEL (2020)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging
Kengo Kidokoro et al.
CIRCULATION (2019)
Mechanisms and disease implications of sirtuin-mediated autophagic regulation
In Hye Lee
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Effects of empagliflozin on nondiabetic salt-sensitive hypertension in uninephrectomized rats
Sua Kim et al.
HYPERTENSION RESEARCH (2019)
Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy
Ryoichi Bessho et al.
SCIENTIFIC REPORTS (2019)
Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats
Alana Aragon-Herrera et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Roles of HIF1α- and HIF2α-regulated BNIP3 in hypoxia-induced injury of neurons
Lei Zhu et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Empagliflozin attenuates diabetic tubulopathy by improving mitochondrial fragmentation and autophagy
Yu Ho Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2019)
SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms
Soravis Osataphan et al.
JCI INSIGHT (2019)
Heart regeneration and the cardiomyocyte cell cycle
Michael Hesse et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2018)
Canagliflozin exerts anti-inflammatory effects by inhibiting intracellular glucose metabolism and promoting autophagy in immune cells
Chenke Xu et al.
BIOCHEMICAL PHARMACOLOGY (2018)
SGLT2 inhibitors: clinical benefits by restoration of normal diurnal metabolism?
Russell L. Esterline et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Sodium-glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice
Shinji Tanaka et al.
KIDNEY INTERNATIONAL (2018)
Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high-fat diet
Susumu Takagi et al.
JOURNAL OF DIABETES INVESTIGATION (2018)
High Basolateral Glucose Increases Sodium-Glucose Cotransporter 2 and Reduces Sirtuin-1 in Renal Tubules through Glucose Transporter-2 Detection
Hiroyuki Umino et al.
SCIENTIFIC REPORTS (2018)
Comprehensive renoprotective effects of ipragliflozin on early diabetic nephropathy in mice
Michitsugu Kamezaki et al.
SCIENTIFIC REPORTS (2018)
Excessive dietary lipid intake provokes an acquired form of lysosomal lipid storage disease in the kidney
Elena Rampanelli et al.
JOURNAL OF PATHOLOGY (2018)
Rapamycin induces autophagy to alleviate acute kidney injury following cerebral ischemia and reperfusion via the mTORC1/ATG13/ULK1 signaling pathway
Yang Su et al.
MOLECULAR MEDICINE REPORTS (2018)
Effects of sodium-glucose cotransporter 2 inhibitor, tofogliflozin, on the indices of renal tubular function in patients with type 2 diabetes
Kiyohide Nunoi et al.
ENDOCRINOLOGY DIABETES & METABOLISM (2018)
SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathy
Paola Cassis et al.
JCI INSIGHT (2018)
Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilation
Laween Uthman et al.
DIABETOLOGIA (2018)
Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts
Masashi Mizuno et al.
PHYSIOLOGICAL REPORTS (2018)
Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
Antonius Baartscheer et al.
DIABETOLOGIA (2017)
Dedicated SNAREs and specialized TRIM cargo receptors mediate secretory autophagy
Tomonori Kimura et al.
EMBO JOURNAL (2017)
High-Fat Diet-Induced Lysosomal Dysfunction and Impaired Autophagic Flux Contribute to Lipotoxicity in the Kidney
Takeshi Yamamoto et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICE
Xiaoxin X. Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Effects of Cobalt Chloride, a Hypoxia-Mimetic Agent, on Autophagy and Atrophy in Skeletal C2C12 Myotubes
Rui Chen et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Selective tubular activation of hypoxia-inducible factor-2α has dual effects on renal fibrosis
Kyoung Hye Kong et al.
SCIENTIFIC REPORTS (2017)
Treatment of diabetic mice with the SGLT2 inhibitor TA-1887 antagonizes diabetic cachexia and decreases mortality
Taichi Sugizaki et al.
NPJ AGING AND MECHANISMS OF DISEASE (2017)
Regulating Autophagy as a Therapeutic Target for Diabetic Nephropathy
Munehiro Kitada et al.
CURRENT DIABETES REPORTS (2017)
Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors
Wataru Ogawa et al.
JOURNAL OF DIABETES INVESTIGATION (2016)
Sirt1 and the Mitochondria
Bor Luen Tang
MOLECULES AND CELLS (2016)
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Renal Effects of Antisense-Mediated Inhibition of SGLT2
Leonie van Meer et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Elevated Endothelial Hypoxia-Inducible Factor-1α Contributes to Glomerular Injury and Promotes Hypertensive Chronic Kidney Disease
Renna Luo et al.
HYPERTENSION (2015)
High-fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT3 loss
Heng Zeng et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Regulation of mTORC1 by PI3K signaling
Christian C. Dibble et al.
TRENDS IN CELL BIOLOGY (2015)
Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway
Young Mi Song et al.
AUTOPHAGY (2015)
Hypoxia signaling pathways: modulators of oxygen-related organelles
Miriam J. Schonenberger et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2015)
Defective Mitophagy in XPA via PARP-1 Hyperactivation and NAD+/SIRT1 Reduction
Evandro Fei Fang et al.
CELL (2014)
Hif-2α Promotes Degradation of Mammalian Peroxisomes by Selective Autophagy
Katharina M. Walter et al.
CELL METABOLISM (2014)
Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
David Z. I. Cherney et al.
CIRCULATION (2014)
Obesity-Mediated Autophagy Insufficiency Exacerbates Proteinuria-induced Tubulointerstitial Lesions
Kosuke Yamahara et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Advanced Glycated End-Products Affect HIF-Transcriptional Activity in Renal Cells
Tzvetanka Bondeva et al.
MOLECULAR ENDOCRINOLOGY (2013)
Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes
Kazuhiro Hasegawa et al.
NATURE MEDICINE (2013)
Autosis is a Na+,K+-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia
Yang Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Nutrient signaling to mTOR and cell growth
Jenna L. Jewell et al.
TRENDS IN BIOCHEMICAL SCIENCES (2013)
Autophagy Guards Against Cisplatin-Induced Acute Kidney Injury
Atsushi Takahashi et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function
Nathan L. Price et al.
CELL METABOLISM (2012)
The Acetylase/Deacetylase Couple CREB-binding Protein/Sirtuin 1 Controls Hypoxia-inducible Factor 2 Signaling
Rui Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Improvement of Cardiac Functions by Chronic Metformin Treatment Is Associated With Enhanced Cardiac Autophagy in Diabetic OVE26 Mice
Zhonglin Xie et al.
DIABETES (2011)
Hypoxia Increases Sirtuin 1 Expression in a Hypoxia-inducible Factor-dependent Manner
Rui Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Autophagy Protects the Proximal Tubule from Degeneration and Acute Ischemic Injury
Tomonori Kimura et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Sirtuin-1 regulation of mammalian metabolism
Matthew P. Gillum et al.
TRENDS IN MOLECULAR MEDICINE (2011)
The role of the Atg1/ULK1 complex in autophagy regulation
Noboru Mizushima
CURRENT OPINION IN CELL BIOLOGY (2010)
Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney
Shinji Kume et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice
Bjoern Hartleben et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
High glucose activates HIF-1-mediated signal transduction in glomerular mesangial cells through a carbohydrate response element binding protein
Tsubasa Isoe et al.
KIDNEY INTERNATIONAL (2010)
SIRT1 Negatively Regulates the Mammalian Target of Rapamycin
Hiyaa Singhee Ghosh et al.
PLOS ONE (2010)
Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis
Shijie Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential
Hiroyuki Mori et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
The human HIF (hypoxia-inducible factor)-3α gene is a HIF-1 target gene and may modulate hypoxic gene induction
Tetsuhiro Tanaka et al.
BIOCHEMICAL JOURNAL (2009)
Hypoxia-Induced Autophagy Is Mediated through Hypoxia-Inducible Factor Induction of BNIP3 and BNIP3L via Their BH3 Domains
Gregory Bellot et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Carles Canto et al.
NATURE (2009)
High fat diet-fed obese rats are highly sensitive to doxorubicin-induced cardiotoxicity
Mayurranjan S. Mitra et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo
Erinn B. Rankin et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Distinct roles of autophagy in the heart during ischemia and reperfusion - Roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy
Yutaka Matsui et al.
CIRCULATION RESEARCH (2007)
Rapamycin prevents early steps of the development of diabetic nephropathy in rats
Yi Yang et al.
AMERICAN JOURNAL OF NEPHROLOGY (2007)
AMPK activation inhibits the expression of HIF-1α induced by insulin and IGF-1
C Treins et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Regulation of erythropoietin production
KU Eckardt et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2005)
In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker
N Mizushima et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
J Brugarolas et al.
GENES & DEVELOPMENT (2004)
Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes
S Shimizu et al.
NATURE CELL BIOLOGY (2004)
Persistent induction of HIF-1α and -2α in cardiomyocytes and stromal cells of ischemic myocardium
JS Jürgensen et al.
FASEB JOURNAL (2004)
Expression of hypoxia-inducible factor-1α and -2α in hypoxic and ischemic rat kidneys
C Rosenberger et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
分享论文
